Cargando…

Multiomics integration reveals the effect of Orexin A on glioblastoma

Objectives: This study involved a multi-omics analysis of glioblastoma (GBM) samples to elaborate the potential mechanism of drug treatment. Methods: The GBM cells treated with or without orexin A were acquired from sequencing analysis. Differentially expressed genes/proteins/metabolites (DEGs/ DEPs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Sha, Huan, Renzheng, Yue, Jianhe, Guo, Jin, Deng, Mei, Wang, Liya, Peng, Shuo, Lin, Xin, Liu, Lin, Wang, Jia, Han, Guoqiang, Zha, Yan, Liu, Jian, Zhang, Jiqin, Tan, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894894/ https://www.ncbi.nlm.nih.gov/pubmed/36744263 http://dx.doi.org/10.3389/fphar.2023.1096159

Ejemplares similares

Mast cell activation mediates blood–brain barrier impairment and cognitive dysfunction in septic mice in a histamine-dependent pathway
por: Yue, Jianhe, et al.
Publicado: (2023)

Orexin, orexin receptor antagonists and central cardiovascular control
por: Carrive, Pascal
Publicado: (2013)

The Role of DACT Family Members in Tumorigenesis and Tumor Progression
por: Zeng, Yu, et al.
Publicado: (2022)

Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonism
por: Dugovic, Christine, et al.
Publicado: (2014)

Orexin A and orexin receptor 1 axonal traffic in dorsal roots at the CNS/PNS interface
por: Colas, Damien, et al.
Publicado: (2014)

Orexin, cardio-respiratory function, and hypertension
por: Li, Aihua, et al.
Publicado: (2014)

Kinetic properties of “dual” orexin receptor antagonists at OX(1)R and OX(2)R orexin receptors
por: Callander, Gabrielle E., et al.
Publicado: (2013)

Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent models
por: Anderson, Rachel I., et al.
Publicado: (2014)

Opportunities and perspectives for developing orexin receptor antagonists
por: Steiner, Michel A., et al.
Publicado: (2014)

Hypocretin (orexin) regulation of sleep-to-wake transitions
por: de Lecea, Luis, et al.
Publicado: (2014)

Orexin receptor antagonists as therapeutic agents for insomnia
por: Equihua, Ana C., et al.
Publicado: (2013)

Different doses of dual orexin receptor antagonists in primary insomnia: a Bayesian network analysis
por: Xue, Tao, et al.
Publicado: (2023)

Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
por: Yeoh, Jiann Wei, et al.
Publicado: (2014)

OX(1) and OX(2) orexin/hypocretin receptor pharmacogenetics
por: Thompson, Miles D., et al.
Publicado: (2014)

Daily Fluctuation of Orexin Neuron Activity and Wiring: The Challenge of “Chronoconnectivity”
por: Azeez, Idris A., et al.
Publicado: (2018)

LSN2424100: a novel, potent orexin-2 receptor antagonist with selectivity over orexin-1 receptors and activity in an animal model predictive of antidepressant-like efficacy
por: Fitch, Thomas E., et al.
Publicado: (2014)

Modulation of sleep behavior in zebrafish larvae by pharmacological targeting of the orexin receptor
por: Pardon, Marie, et al.
Publicado: (2022)

Orexin 1 receptor antagonists in compulsive behavior and anxiety: possible therapeutic use
por: Merlo Pich, Emilio, et al.
Publicado: (2014)

The hypocretin/orexin antagonist almorexant promotes sleep without impairment of performance in rats
por: Morairty, Stephen R., et al.
Publicado: (2014)

Multiomics Analysis Reveals the Prognostic Non-tumor Cell Landscape in Glioblastoma Niches
por: Xiao, Zixuan, et al.
Publicado: (2021)

Integrative Multiomics Analysis of the Heat Stress Response of Enterococcus faecium
por: Wang, Li, et al.
Publicado: (2023)

Intranasal neuropeptide Y is most effective in some aspects of acute stress compared to melatonin, oxytocin and orexin
por: Zubkov, Eugene, et al.
Publicado: (2022)

Pharmacological or genetic orexin1 receptor inhibition attenuates MK-801 induced glutamate release in mouse cortex
por: Aluisio, Leah, et al.
Publicado: (2014)

Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment
por: Tang, Lin, et al.
Publicado: (2021)

Frutescone O from Baeckea frutescens Blocked TLR4-Mediated Myd88/NF-κB and MAPK Signaling Pathways in LPS Induced RAW264.7 Macrophages
por: Lin, Xiaobing, et al.
Publicado: (2021)

Embracing Integrative Multiomics Approaches
por: Rotroff, Daniel M., et al.
Publicado: (2016)

Apatinib for recurrent/progressive glioblastoma multiforme: A salvage option
por: Zhang, Hong-Hong, et al.
Publicado: (2022)

A Multiomics Approach Unravels New Toxins With Possible In Silico Antimicrobial, Antiviral, and Antitumoral Activities in the Venom of Acanthoscurria rondoniae
por: Câmara, Guilherme A., et al.
Publicado: (2020)

Differential actions of orexin receptors in brainstem cholinergic and monoaminergic neurons revealed by receptor knockouts: implications for orexinergic signaling in arousal and narcolepsy
por: Kohlmeier, Kristi A., et al.
Publicado: (2013)

The selective orexin receptor 1 antagonist ACT-335827 in a rat model of diet-induced obesity associated with metabolic syndrome
por: Steiner, Michel A., et al.
Publicado: (2013)

Suvorexant, an FDA-approved dual orexin receptor antagonist, reduces oxycodone self-administration and conditioned reinstatement in male and female rats
por: Illenberger, Jessica M., et al.
Publicado: (2023)

Multiomics profiling of paired primary and recurrent glioblastoma patient tissues
por: Dekker, Lennard J M, et al.
Publicado: (2020)

Functional cardiac orexin receptors: role of orexin-B/orexin 2 receptor in myocardial protection
por: Patel, Vanlata H., et al.
Publicado: (2018)

Effects of a newly developed potent orexin-2 receptor-selective antagonist, compound 1 m, on sleep/wakefulness states in mice
por: Etori, Keishi, et al.
Publicado: (2014)

Posaconazole inhibits the stemness of cancer stem-like cells by inducing autophagy and suppressing the Wnt/β-catenin/survivin signaling pathway in glioblastoma
por: Wang, Hua, et al.
Publicado: (2022)

Integrative multiomics-histopathology analysis for breast cancer classification
por: Ektefaie, Yasha, et al.
Publicado: (2021)

Multiomics analysis of tumor mutational burden across cancer types
por: Li, Lin, et al.
Publicado: (2021)

UBA1 inhibition contributes radiosensitization of glioblastoma cells via blocking DNA damage repair
por: Wu, Changyong, et al.
Publicado: (2023)

Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation
por: Bonaventure, Pascal, et al.
Publicado: (2017)

Immune Checkpoint in Glioblastoma: Promising and Challenging
por: Huang, Jing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_53p1t7u3plm0ar7b4r1airg4e4